Abstract
The present study was aimed at assessing the anti-depressant activity of the alcoholic extracts of the leaves of Alternanthera sessilis and Clerodendrum infortunatum. The activity was studied on Swiss Albino mice using the Tail Suspension Test and the Forced Swim Test, at doses of 100mg/kg b.w. and 20 mg/kg b.w. with Diazepam as the standard drug. Both the extracts, at higher dose, exhibited significant reduction in the duration of immobility. The alcoholic extract of Clerodendrum infortunatum was the most active extract in both the animal models, at a dose of 200 mg/kg b.w. Thus this study verifies the claims of antidepressant activity of these plants in the tradional medicine.
Keywords: Alternanthera sessilis, anti-depressant, clerodendrum infortunatum.
The Natural Products Journal
Title:Antidepressant Like Effects of Alternanthera sessilis and Clerodendrum infortunatum Leaves Extract in Immobility Models
Volume: 4 Issue: 1
Author(s): Rajiv Gupta and Hemant K. Singh
Affiliation:
Keywords: Alternanthera sessilis, anti-depressant, clerodendrum infortunatum.
Abstract: The present study was aimed at assessing the anti-depressant activity of the alcoholic extracts of the leaves of Alternanthera sessilis and Clerodendrum infortunatum. The activity was studied on Swiss Albino mice using the Tail Suspension Test and the Forced Swim Test, at doses of 100mg/kg b.w. and 20 mg/kg b.w. with Diazepam as the standard drug. Both the extracts, at higher dose, exhibited significant reduction in the duration of immobility. The alcoholic extract of Clerodendrum infortunatum was the most active extract in both the animal models, at a dose of 200 mg/kg b.w. Thus this study verifies the claims of antidepressant activity of these plants in the tradional medicine.
Export Options
About this article
Cite this article as:
Gupta Rajiv and K. Singh Hemant, Antidepressant Like Effects of Alternanthera sessilis and Clerodendrum infortunatum Leaves Extract in Immobility Models, The Natural Products Journal 2014; 4 (1) . https://dx.doi.org/10.2174/2210315504666140515004826
DOI https://dx.doi.org/10.2174/2210315504666140515004826 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions
Current Neuropharmacology Cognitive Remediation Therapy of Social Cognition in Schizophrenia: A Critical Review
Current Psychiatry Reviews Preface [Hot topic: Mitochondria as a Target of Medicinal Chemistry (Guest Editor: Dongchon Kang)]
Current Medicinal Chemistry Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders
Combinatorial Chemistry & High Throughput Screening Perioperative Heart-Brain Axis Protection in Obese Surgical Patients: The Nutrigenomic Approach
Current Medicinal Chemistry In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Drug Metabolism Letters Bone Marrow-Derived Mesenchymal Stem Cells Contribute to the Reduction of Amyloid-β Deposits and the Improvement of Synaptic Transmission in a Mouse Model of Pre-Dementia Alzheimer’s Disease
Current Alzheimer Research Editorial: [The “Hair of the Dog”: A Useful Hangover Remedy or a Predictor of Future Problem Drinking?]
Current Drug Abuse Reviews Recent Progress in the Preparation of Eco-friendly Lubricant and Fuel Additives through Organic Transformations of Biomaterials
Mini-Reviews in Organic Chemistry Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Small Molecules Activating TrkB Receptor for Treating a Variety of CNS Disorders
CNS & Neurological Disorders - Drug Targets Circular Micro-Proteins and Mechanisms of Cyclization
Current Pharmaceutical Design Pediatric Obesity Epidemic: Problem and Solutions
Current Pharmaceutical Design Development of RET Kinase Inhibitors for Targeted Cancer Therapy
Current Medicinal Chemistry UCLA’s Molecular Screening Shared Resource: Enhancing Small Molecule Discovery with Functional Genomics and New Technology
Combinatorial Chemistry & High Throughput Screening Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) A Mendelian Randomization Study on Infant Length and Type 2 Diabetes Mellitus Risk
Current Gene Therapy The Role of the Calcium-Sensing Receptor in Human Pathophysiology
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Good at Heart: Preserving Cardiac Metabolism during aging
Current Diabetes Reviews Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases
Current Medicinal Chemistry